AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2400198 — intervention group
Group type: EXPERIMENTAL
Intervention: nifedipine 10 mg b.i.d.
Number of subjects: 10
Study 2400198 — intervention group
Group type: EXPERIMENTAL
Intervention: diltiazem 120 mg b.i.d.
Number of subjects: 10
Study 2400198 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 367025 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low-dose calcium heparin
Number of subjects: 0
Study 367025 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous low-dose sodium heparin
Number of subjects: 0
Study 31916704 — intervention group
Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam) 5 mg
Number of subjects: 0
Study 31916704 — intervention group
Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam) 10 mg
Number of subjects: 0
Study 31916704 — intervention group
Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam) 20 mg
Number of subjects: 0
Study 31916704 — intervention group
Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam) 2 x 10 mg
Number of subjects: 0
Study 31916704 — intervention group
Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam)
Number of subjects: 0
Study 31034106 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 196
Study 31034106 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and cognitive behavioural therapy treatment
Number of subjects: 196
Study 28697043 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol (OE) 2 mg/day
Number of subjects: 150
Study 28697043 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol (OE) 2 mg/day + medroxyprogesterone acetate (MPA) 5 mg/day
Number of subjects: 150
Study 28697043 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 1 mg/day
Number of subjects: 150
Study 28697043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 25965710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 6068
Study 25965710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6068
Study 23377899 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased levels of catalytic iron
Number of subjects: 1701
Study 23377899 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of catalytic iron
Number of subjects: 1701
Study 23377899 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted levels of catalytic iron
Number of subjects: 1701
Study 23377899 — intervention group
Group type: COMPARATOR
Intervention: Catalytic iron
Number of subjects: 1701
Study 21844815 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquacel Ag
Number of subjects: 20
Study 21844815 — intervention group
Group type: COMPARATOR
Intervention: Glucan II
Number of subjects: 20
Study 19264279 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music for 1 hour a day for 7 consecutive days
Number of subjects: 60
Study 19264279 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 17185126 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamide peroxide 15%
Number of subjects: 26
Study 17185126 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 26
Study 15565569 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA/MTZ
Number of subjects: 80
Study 15565569 — intervention group
Group type: COMPARATOR
Intervention: UDCA/placebo
Number of subjects: 80
Study 11594949 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% cyclosporine qid
Number of subjects: 39
Study 11594949 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% cidofovir qid
Number of subjects: 39
Study 11594949 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% cidofovir + 1% cyclosporine qid
Number of subjects: 39
Study 11594949 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride qid
Number of subjects: 39
Study 9781629 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index (LGI) diet
Number of subjects: 61
Study 9781629 — intervention group
Group type: COMPARATOR
Intervention: High glycemic index (HGI) diet
Number of subjects: 61
Study 9781629 — intervention group
Group type: EXPERIMENTAL
Intervention: Adipocyte TNF-alpha production
Number of subjects: 61
Study 8153331 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 245
Study 8153331 — intervention group
Group type: COMPARATOR
Intervention: Ethiodized poppy-seed oil
Number of subjects: 245
Study 3292711 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate, and fluorouracil (CMF)
Number of subjects: 627
Study 3292711 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate, 5-FU, and prednisone (CMFP)
Number of subjects: 627
Study 3292711 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate, 5-FU, prednisone, and tamoxifen (CMFPT)
Number of subjects: 627
Study 3292711 — intervention group
Group type: COMPARATOR
Intervention: Observation (for postmenopausal patients)
Number of subjects: 627
Study 3292711 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy radiation added to chemotherapy
Number of subjects: 627
Study 30580488 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mL syringe
Number of subjects: 200
Study 30580488 — intervention group
Group type: COMPARATOR
Intervention: 10-mL syringe
Number of subjects: 200
Study 28114618 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 1709
Study 28114618 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1709
Study 28114618 — intervention group
Group type: COMPARATOR
Intervention: Nonenrolled eligible patients (ZES or EES)
Number of subjects: 1709
Study 25734448 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive chlorinator
Number of subjects: 20
Study 25734448 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatabs
Number of subjects: 20
Study 25734448 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 23798329 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy for patients aged < 50 years
Number of subjects: 2276
Study 23798329 — intervention group
Group type: COMPARATOR
Intervention: Intensive chemotherapy for patients aged ≥ 50 years
Number of subjects: 2276
Study 23798329 — intervention group
Group type: COMPARATOR
Intervention: Intensive chemotherapy for patients aged 50 to 54 years
Number of subjects: 2276
Study 23798329 — intervention group
Group type: COMPARATOR
Intervention: Intensive chemotherapy for patients aged 55 to 59 years
Number of subjects: 2276
Study 23798329 — intervention group
Group type: COMPARATOR
Intervention: Intensive chemotherapy for patients aged 60 to 64 years
Number of subjects: 2276
Study 21672353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent antegrade isothermic blood cardioplegia
Number of subjects: 0
Study 21672353 — intervention group
Group type: COMPARATOR
Intervention: Antegrade plus continuous retrograde isothermic blood cardioplegia
Number of subjects: 0
Study 19840568 — intervention group
Group type: EXPERIMENTAL
Intervention: Final ACT >330 seconds
Number of subjects: 1234
Study 19840568 — intervention group
Group type: COMPARATOR
Intervention: Final ACT tertiles (lower to upper)
Number of subjects: 1234
Study 19840568 — intervention group
Group type: COMPARATOR
Intervention: Final ACT tertiles
Number of subjects: 1234
Study 16972831 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal laryngeal mask airway (ProSeal LMA)
Number of subjects: 60
Study 16972831 — intervention group
Group type: COMPARATOR
Intervention: Nasal cannulae (NC)
Number of subjects: 60
Study 14603549 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program consisting of aerobic and strength-building components, performed without direct supervision for six months
Number of subjects: 24
Study 14603549 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group (control)
Number of subjects: 24
Study 10932443 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated treatment program for dual disorders (12 months duration)
Number of subjects: 0
Study 8620097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 20
Study 8620097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1436364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia lata
Number of subjects: 69
Study 1436364 — intervention group
Group type: EXPERIMENTAL
Intervention: Periosteum (pericranium)
Number of subjects: 69
Study 1436364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia of temporalis muscle
Number of subjects: 69
Study 1436364 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyodura (lyophilised cerebral dura mater)
Number of subjects: 69
Study 1436364 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted sutures
Number of subjects: 69
Study 1436364 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 69
Study 1436364 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment without dural closure
Number of subjects: 69
Study 6373685 — intervention group
Group type: EXPERIMENTAL
Intervention: Misonidazole (radiosensitizing drug)
Number of subjects: 62
Study 6373685 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 62
Study 30043093 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing regimen A (half an hour before breakfast)
Number of subjects: 84
Study 30043093 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing regimen B (an hour before the main meal of the day)
Number of subjects: 84
Study 30043093 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing regimen C (at bedtime, minimally 2 hours after dinner)
Number of subjects: 84
Study 26797912 — intervention group
Group type: COMPARATOR
Intervention: Radiographs only
Number of subjects: 180
Study 26797912 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-D CT and radiographs
Number of subjects: 180
Study 26797912 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D CT, 2-D CT and radiographs
Number of subjects: 180
Study 25643432 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intracoronary UFH (1,000 IU intracoronary UFH)
Number of subjects: 200
Study 25643432 — intervention group
Group type: COMPARATOR
Intervention: Control group (70-100 IU/kg intravenous UFH)
Number of subjects: 200
Study 22608852 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive midvastus (MMV) approach
Number of subjects: 80
Study 22608852 — intervention group
Group type: COMPARATOR
Intervention: Standard medial parapatellar (MPP) approach
Number of subjects: 80
Study 20189026 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (intermittent arm ischaemia through four cycles of 5‐min inflation and 5‐min deflation of a blood‐pressure cuff)
Number of subjects: 333
Study 20189026 — intervention group
Group type: COMPARATOR
Intervention: Control group (without remote conditioning)
Number of subjects: 333
Study 20189026 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning
Number of subjects: 333
Study 20189026 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Remote ischaemic conditioning and Control)
Number of subjects: 333
Study 18829079 — intervention group
Group type: EXPERIMENTAL
Intervention: New anastomosis technique (single-suture, single-knot, running procedure)
Number of subjects: 50
Study 18829079 — intervention group
Group type: COMPARATOR
Intervention: Double running suture (control group)
Number of subjects: 50
Study 11558045 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Gy radiotherapy
Number of subjects: 31
Study 11558045 — intervention group
Group type: COMPARATOR
Intervention: 0.5 Gy (placebo dose)
Number of subjects: 31
Study 10771885 — intervention group
Group type: COMPARATOR
Intervention: Partial exchange transfusion with normal saline
Number of subjects: 47
Study 10771885 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial exchange transfusion with fresh plasma
Number of subjects: 47
Study 7514356 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous IV infusion of ketorolac
Number of subjects: 21
Study 7514356 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 21
Study 3438618 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulants
Number of subjects: 0
Study 3438618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31981733 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS/LABA (Mometasone Furoate/Formoterol)
Number of subjects: 8447
Study 31748208 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet rich plasma injection
Number of subjects: 230
Study 31748208 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection (dry needle)
Number of subjects: 230
Study 28894836 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy (TRT) consisting of directive counseling and acoustic enrichment using combination hearing aids and sound generators
Number of subjects: 0
Study 28894836 — intervention group
Group type: COMPARATOR
Intervention: Standard of care treatment (SC) consisting of general aural rehabilitation counseling and hearing aids
Number of subjects: 0
Study 25724213 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (1 × 10^9 colony-forming units of Lactobacillus rhamnosus GG and Bifidobacterium infantis per day)
Number of subjects: 184
Study 25724213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study 25724213 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 184
Study 22930403 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids (300 mg/day)
Number of subjects: 100
Study 21810242 — intervention group
Group type: EXPERIMENTAL
Intervention: Task shifting to nurses for prescribing antiretrovirals (ARVs) for uncomplicated patients, combined with integration of HIV care into primary care services.
Number of subjects: 0
Study 21810242 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and guidelines for nurse ART prescription, local management teams, and implementation toolkit.
Number of subjects: 0
Study 18339656 — intervention group
Group type: EXPERIMENTAL
Intervention: Damon3 self‐ligating bracket system
Number of subjects: 62
Study 18339656 — intervention group
Group type: COMPARATOR
Intervention: Synthesis conventional ligating bracket system
Number of subjects: 62
Study 17182420 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 0
Study 17182420 — intervention group
Group type: COMPARATOR
Intervention: Relaxation Training (RT)
Number of subjects: 0
Study 12919265 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-sensory stimulation (MSS)
Number of subjects: 136
Study 12919265 — intervention group
Group type: COMPARATOR
Intervention: Activity group (playing card games, looking at photographs, doing quizzes, etc.)
Number of subjects: 136
Study 11000317 — intervention group
Group type: EXPERIMENTAL
Intervention: RMGIC/CR sandwich restorations
Number of subjects: 118
Study 11000317 — intervention group
Group type: COMPARATOR
Intervention: CR restorations
Number of subjects: 118
Study 11000317 — intervention group
Group type: EXPERIMENTAL
Intervention: RMGIC/CR restorations
Number of subjects: 118
Study 11000317 — intervention group
Group type: EXPERIMENTAL
Intervention: CR fillings
Number of subjects: 118
Study 9278875 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-labeled tetrofosmin
Number of subjects: 160
Study 9278875 — intervention group
Group type: COMPARATOR
Intervention: 201Tl
Number of subjects: 160
Study 8466742 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (10 mg once daily)
Number of subjects: 0
Study 8466742 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 mg once daily)
Number of subjects: 0
Study 8466742 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg once daily) added to nitrendipine
Number of subjects: 0
Study 8466742 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg once daily) added to isradipine
Number of subjects: 0
Study 8466742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29930023 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) <120 mm Hg
Number of subjects: 33357
Study 29930023 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) ≥160 mm Hg
Number of subjects: 33357
Study 29930023 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP) <60 mm Hg
Number of subjects: 33357
Study 29930023 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure
Number of subjects: 33357
Study 29930023 — intervention group
Group type: COMPARATOR
Intervention: Systolic Blood Pressure (SBP) 120-129 mm Hg
Number of subjects: 33357
Study 27274349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton-roll vibration method (a combination of topical anesthesia gel, cotton roll, and vibration for physical distraction)
Number of subjects: 48
Study 27274349 — intervention group
Group type: COMPARATOR
Intervention: Routine topical anesthesia (control)
Number of subjects: 48
Study 26369799 — intervention group
Group type: EXPERIMENTAL
Intervention: High motivation to quit
Number of subjects: 584
Study 26369799 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for gradual reduction in cigarettes
Number of subjects: 584
Study 26369799 — intervention group
Group type: EXPERIMENTAL
Intervention: Don't know enjoyment of smoking
Number of subjects: 584
Study 26369799 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer family or friends who smoke
Number of subjects: 584
Study 22957829 — intervention group
Group type: EXPERIMENTAL
Intervention: Early response cutoff of 51.6% PANSS total score improvement by week 6
Number of subjects: 132
Study 21068682 — intervention group
Group type: EXPERIMENTAL
Intervention: GF (glucose + fructose) during SE (strength exercise)
Number of subjects: 20
Study 21068682 — intervention group
Group type: EXPERIMENTAL
Intervention: GF (glucose + fructose) during EE (endurance exercise)
Number of subjects: 20
Study 18445178 — intervention group
Group type: COMPARATOR
Intervention: Captopril (100 mg) alone
Number of subjects: 15
Study 18445178 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (100 mg) with low-dose bendroflumethiazide (1.25 mg)
Number of subjects: 15
Study 17154746 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychotherapeutic intervention
Number of subjects: 62
Study 17154746 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 62
Study 12592541 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 264
Study 12592541 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 264
Study 11008903 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of nonrecreational physical activity
Number of subjects: 5377
Study 11008903 — intervention group
Group type: COMPARATOR
Intervention: Very active men
Number of subjects: 5377
Study 11008903 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of recreational activity
Number of subjects: 5377
Study 11008903 — intervention group
Group type: EXPERIMENTAL
Intervention: Various anthropometric variables
Number of subjects: 5377
Study 9093546 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced fat products
Number of subjects: 241
Study 9093546 — intervention group
Group type: COMPARATOR
Intervention: Full-fat products
Number of subjects: 241
Study 8251413 — intervention group
Group type: EXPERIMENTAL
Intervention: Schedule M (intermediate dose methotrexate with folinic acid rescue)
Number of subjects: 266
Study 8251413 — intervention group
Group type: COMPARATOR
Intervention: Schedule D (daunorubicin)
Number of subjects: 266
Study 8251413 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall remission rate
Number of subjects: 266
Study 8251413 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors predictive of a lower remission rate
Number of subjects: 266
Study 8251413 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic factors for those who entered remission
Number of subjects: 266
Study 8251413 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to achieve remission
Number of subjects: 266
Study 8251413 — intervention group
Group type: EXPERIMENTAL
Intervention: Historical comparison with preceding MRC adult trial
Number of subjects: 266
Study 3895828 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine duration of oral anticoagulation (standard duration)
Number of subjects: 80
Study 3895828 — intervention group
Group type: COMPARATOR
Intervention: 50% reduction in duration of oral anticoagulation (reduced duration)
Number of subjects: 80
Study 31648881 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 111
Study 31648881 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 111
Study 30167675 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (10 mg) combined with physical therapy
Number of subjects: 64
Study 30167675 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with physical therapy
Number of subjects: 64
Study 27861718 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively stimulating activities (daily for up to 30 days)
Number of subjects: 283
Study 27861718 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 283
Study 27861718 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively stimulating activities
Number of subjects: 283
Study 25448081 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathological gambling
Number of subjects: 72
Study 25448081 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine dependence
Number of subjects: 72
Study 25448081 — intervention group
Group type: COMPARATOR
Intervention: Non-addicted group (control)
Number of subjects: 72
Study 22122590 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced adherence support from peer-supporters
Number of subjects: 640
Study 22122590 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 640
Study 20013936 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 411
Study 20013936 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 411
Study 20013936 — intervention group
Group type: EXPERIMENTAL
Intervention: Converted from laparoscopic to open surgery
Number of subjects: 411